Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer
Clinical trial NCT02281383 · COMPLETED
Trial details
- NCT number
- NCT02281383
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2022-02-24
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.